Porvoo sarcopenia and nutrition trial: effects of protein supplementation on functional performance in home-dwelling sarcopenic older people - study protocol for a randomized controlled trial

被引:16
作者
Bjorkman, Mikko P. [1 ]
Suominen, Merja H. [2 ]
Pitkala, Kaisu H. [3 ]
Finne-Soveri, Harriet U. [4 ]
Tilvis, Reijo S. [1 ]
机构
[1] Univ Helsinki, Dept Internal Med, Geriatr Unit, Hus Helsinki 00029, Finland
[2] Soc Memory Disorders Expertise Finland, Helsinki 00240, Finland
[3] Univ Helsinki, Cent Hosp, Dept Gen Practice, Unit Gen Practice, Helsinki 00014, Finland
[4] Natl Inst Hlth & Welf, FI-00271 Helsinki, Finland
关键词
Sarcopenia; Frailty; Cachexia; Older people; Community-dwelling; Randomized controlled trial; FRAIL ELDERLY-PEOPLE; PHYSICAL PERFORMANCE; ALZHEIMERS-DISEASE; DOUBLE-BLIND; MUSCLE MASS; PREVENTION; STRENGTH; EXERCISE; SCORES; ADULTS;
D O I
10.1186/1745-6215-14-387
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
Background: Age-related muscle loss (that is, sarcopenia) is a common health problem among older people. Physical exercise and dietary protein have been emphasized in prevention and treatment of sarcopenia. Rigorous trials investigating the effects of protein supplementation on physical performance in sarcopenic populations are still scarce. The aim of this study is to investigate the effects of protein supplementation along with simple home-based exercises on physical performance among home-dwelling sarcopenic older people. Methods/Design: During 2012 the entire 75 and older population (N = 3,275) living in Porvoo, Finland was contacted via a postal questionnaire. Persons at risk of sarcopenia are screened with hand grip strength and gait speed. Poorly performing persons are further examined by segmental bioimpendance spectroscopy to determine their skeletal muscle index. Sarcopenic patients (target N = 250) will be enrolled in a 12-month randomized controlled trial with three arms: 1) no supplementation, 2) protein supplementation (20 grams twice a day), and 3) isocaloric placebo. All the participants will receive instructions on simple home-based exercises, dietary protein, and vitamin D supplementation (20 mu g/d). The recruitment of patients will be completed during 2013. The primary endpoint of the trial is the change in short physical performance battery score and percentage of patients maintaining or improving their physical performance. Secondary endpoints will be, among other things, changes in muscle functions, nutritional status, body composition, cognition, quality of life, use of health care services, falls, and mortality. The assessment times will be 0, 6, 12 and 24 months. Discussion: To our knowledge, this is the first large scale randomized controlled trial among community dwelling older people with sarcopenia that focuses on the effects of protein supplementation on physical performance.
引用
收藏
页数:7
相关论文
共 36 条
[1]
Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials [J].
Bischoff-Ferrari, H. A. ;
Dawson-Hughes, B. ;
Staehelin, H. B. ;
Orav, J. E. ;
Stuck, A. E. ;
Theiler, R. ;
Wong, J. B. ;
Egli, A. ;
Kiel, D. P. ;
Henschkowski, J. .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 :843
[2]
Whey protein supplementation in nursing home residents. A randomized controlled trial [J].
Bjorkman, M. P. ;
Finne-Soveri, H. ;
Tilvis, R. S. .
EUROPEAN GERIATRIC MEDICINE, 2012, 3 (03) :161-166
[3]
Bioimpedance spectroscopy as a measure of physical functioning in nursing home residents [J].
Bjorkman, Mikko P. ;
Finne-Soveri, Harriet ;
Pilvi, Taru K. ;
Tilvis, Reijo S. .
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 24 (06) :612-618
[4]
Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3
[5]
Sarcopenia: European consensus on definition and diagnosis [J].
Cruz-Jentoft, Alfonso J. ;
Baeyens, Jean Pierre ;
Bauer, Juergen M. ;
Boirie, Yves ;
Cederholm, Tommy ;
Landi, Francesco ;
Martin, Finbarr C. ;
Michel, Jean-Pierre ;
Rolland, Yves ;
Schneider, Stephane M. ;
Topinkova, Eva ;
Vandewoude, Maurits ;
Zamboni, Mauro .
AGE AND AGEING, 2010, 39 (04) :412-423
[7]
Value of flow diagrams in reports of randomized controlled trials [J].
Egger, M ;
Jüni, P ;
Bartlett, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (15) :1996-1999
[8]
Development of a New Patient-Reported Outcome Measure in Sarcopenia [J].
Evans, Christopher J. ;
Chiou, Chiun-Fang ;
Fitzgerald, Kristina A. ;
Evans, William J. ;
Ferrell, Betty R. ;
Dale, William ;
Fried, Linda P. ;
Gandra, Shravanthi R. ;
Dennee-Sommers, Brooke ;
Patrick, Donald L. .
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2011, 12 (03) :226-233
[9]
Evans WJ, 2008, J GERONTOL A-BIOL, V63, P160
[10]
MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198